Eric Lattmann

943 total citations
53 papers, 730 citations indexed

About

Eric Lattmann is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eric Lattmann has authored 53 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 18 papers in Molecular Biology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eric Lattmann's work include Neuropeptides and Animal Physiology (13 papers), Organic Chemistry Synthesis Methods (9 papers) and Synthesis and pharmacology of benzodiazepine derivatives (7 papers). Eric Lattmann is often cited by papers focused on Neuropeptides and Animal Physiology (13 papers), Organic Chemistry Synthesis Methods (9 papers) and Synthesis and pharmacology of benzodiazepine derivatives (7 papers). Eric Lattmann collaborates with scholars based in United Kingdom, Thailand and Germany. Eric Lattmann's co-authors include Yvonne Perrie, Sagida Bibi, Afzal R. Mohammed, H. M. R. Hoffmann, M. John Plater, Nison Sattayasai, Harjit Singh, Jintana Sattayasai, Dennis Christensen and David C. Billington and has published in prestigious journals such as Journal of Controlled Release, Tetrahedron and International Journal of Pharmaceutics.

In The Last Decade

Eric Lattmann

52 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Lattmann United Kingdom 13 322 265 112 73 64 53 730
Chiho Kawachi Japan 6 608 1.9× 578 2.2× 82 0.7× 85 1.2× 55 0.9× 9 987
Marcelo F. Masman Netherlands 15 164 0.5× 554 2.1× 76 0.7× 88 1.2× 40 0.6× 28 789
Allan B. Gamble New Zealand 14 340 1.1× 349 1.3× 56 0.5× 112 1.5× 25 0.4× 39 784
Darko Kocjan Slovenia 14 116 0.4× 206 0.8× 66 0.6× 56 0.8× 46 0.7× 41 608
Dionissios Papaioannou Greece 17 458 1.4× 513 1.9× 32 0.3× 59 0.8× 95 1.5× 83 970
Martin Conda‐Sheridan United States 18 594 1.8× 516 1.9× 164 1.5× 41 0.6× 100 1.6× 55 1.2k
Suman Ghosh India 21 295 0.9× 610 2.3× 82 0.7× 40 0.5× 70 1.1× 39 1.1k
Ryszard Andruszkiewicz Poland 17 410 1.3× 509 1.9× 33 0.3× 40 0.5× 83 1.3× 112 1.1k
Rosa Iacovino Italy 18 314 1.0× 523 2.0× 127 1.1× 47 0.6× 25 0.4× 52 903
Sabine Chierici France 15 232 0.7× 316 1.2× 57 0.5× 40 0.5× 74 1.2× 26 545

Countries citing papers authored by Eric Lattmann

Since Specialization
Citations

This map shows the geographic impact of Eric Lattmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Lattmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Lattmann more than expected).

Fields of papers citing papers by Eric Lattmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Lattmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Lattmann. The network helps show where Eric Lattmann may publish in the future.

Co-authorship network of co-authors of Eric Lattmann

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Lattmann. A scholar is included among the top collaborators of Eric Lattmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Lattmann. Eric Lattmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lattmann, Eric, et al.. (2018). CCK-Antagonist PNB-081 (Isobutyl-5-Hydroxy-5-Phenyl-Pyrrol2-One) as Adjunct to Opiates. 4(4). 13–23. 1 indexed citations
2.
4.
Lattmann, Eric, et al.. (2016). Cholecystokinin-1 receptor antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents. MedChemComm. 7(6). 1138–1145. 8 indexed citations
6.
Chaithongyot, Supattra, Asgar Ali, Gulsiri Senawong, et al.. (2015). Anticancer Effects of Curcuma C20-Dialdehyde against Colon and Cervical Cancer Cell Lines. Asian Pacific Journal of Cancer Prevention. 16(15). 6513–6519. 5 indexed citations
7.
Sattayasai, Jintana, et al.. (2012). Antipyretic, analgesic and anti-oxidative activities of Aquilaria crassna leaves extract in rodents. Journal of Ayurveda and Integrative Medicine. 3(4). 175–175. 37 indexed citations
8.
Bibi, Sagida, Randip Kaur, Malou Henriksen‐Lacey, et al.. (2010). Microscopy imaging of liposomes: From coverslips to environmental SEM. International Journal of Pharmaceutics. 417(1-2). 138–150. 103 indexed citations
10.
Lattmann, Eric, et al.. (2008). Part 2. Long term in vivo/in vitro evaluation of the Cholecystokinin antagonists: N-(5-methyl-3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylurea MPP and carboxamide MPM.. PubMed. 2(6). 344–52. 4 indexed citations
11.
Lattmann, Eric, et al.. (2007). Antibacterial Activity of 3-Substituted Pyrrole-2,5-diones Against Pseudomonas Aeruginosa. Letters in Drug Design & Discovery. 4(7). 513–519. 4 indexed citations
12.
Lattmann, Eric, et al.. (2006). Novel Anti-bacterials Against MRSA: Synthesis of Focussed Combinatorial Libraries of Tri-Substituted 2(5H)-Furanones. Current Drug Discovery Technologies. 3(2). 125–134. 39 indexed citations
14.
Lattmann, Eric, et al.. (2005). Synthesis and antibacterial activities of 5-hydroxy-4-amino-2(5H)-furanones. Bioorganic & Medicinal Chemistry Letters. 15(4). 919–921. 60 indexed citations
15.
Lattmann, Eric, et al.. (2004). Cytotoxicity of 3,4-dihalogenated 2(5H)-furanones. Journal of Pharmacy and Pharmacology. 56(9). 1163–1170. 19 indexed citations
16.
Zheng, Qin‐Guo, Yang Wang, & Eric Lattmann. (2003). Synthesis of S6-(2,4-dinitrophenyl)-6-thioguanosine phosphoramidite and its incorporation into oligoribonucleotides. Bioorganic & Medicinal Chemistry Letters. 13(19). 3141–3144. 6 indexed citations
17.
Wang, Yang, Eric Lattmann, & Qin‐Guo Zheng. (2003). Preparation of 6-Thioguanosine Phosphoramidite for Oligoribonucleotide Synthesis. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 1247–1249. 2 indexed citations
19.
Plater, M. John, et al.. (2000). Heterocyclic free radicals. Part 1. 4,5-Diazafluorene derivatives of Koelsch’s free radical: an EPR and metal-ion complexation study †. Journal of the Chemical Society Perkin Transactions 1. 971–979. 70 indexed citations
20.
Lattmann, Eric, et al.. (1999). Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part One: Construction of a sub-library of halogenated 5-alkoxy-2(5H)-furanones.. PubMed. 16(3). 237–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026